Delivery Order SPE2DB25D3404-SPE2DB25FUPJC
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,423.92, is for the delivery of 4,568,171,219 units of Isosorbide Mononitrate 20 mg tablets in 100-count packages. The contract is a firm-fixed-price, non-set-aside award with a performance period ending on May 8, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,266.36 by the Defense Logistics Agency (DLA) on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract, which is not set-aside and competitively awarded, calls for the delivery of Ibsrela 50 mg tablets in quantities of 60 units. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a $1,378.34 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $18,339.50 on July 18, 2025, with an ultimate completion date of July 21, 2025. The award is for Gemtesa 75 mg tablets in a quantity of 90 units under a firm fixed price contract type with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $1,102.76 to AmerisourceBergen Drug Corp for the supply of Nifedipine ER 30 mg tablets (100-count units), with an ultimate completion date of July 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contractor is based in Conshohocken, Pennsylvania, which also serves as the place of performance for this pharmaceutical supply contract. This delivery order is...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,541.84, is a firm fixed-price delivery order with no set-aside designation, indicating open competition. The contract provides for the delivery of various pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications across multiple therapeutic...
- This is a $1,102.86 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order does not have a set-aside designation, indicating...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,037.05, is a firm fixed-price delivery order for the procurement of pharmaceutical and medical products, including medications across various therapeutic areas such as diabetes, neurology, and pain management. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,749.60 contract is for the supply of various pharmaceutical and medical products, including medications across multiple therapeutic categories such as diabetes, neurology, pain management, and specialty pharmaceuticals. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,022.60 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide pharmaceutical products and medical supplies. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of medical commodities to the Department of...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUPJCDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,313.95 to AmerisourceBergen Drug Corp for the supply of Isosorbide Dinitrate 40 mg tablets (100-count units). This firm fixed-price delivery order, awarded on July 18, 2025, was completed by July 21, 2025, with no set-aside designation applied. The award utilizes a competitive procurement process, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical supply requirements. Performance of this delivery order occurs at the vendor's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026 that serves as the company's primary vehicle for supplying pharmaceuticals and medical supplies to military and veteran healthcare systems worldwide. AmerisourceBergen's comprehensive federal contract portfolio demonstrates its role as a critical pharmaceutical distributor for the Defense Health Agency and other federal healthcare programs, with contract awards spanning generic and brand-name medications, vaccines, and specialized medical supplies across multiple therapeutic categories. The DLA Troop Support is planning next-generation Pharmaceutical Prime Vendor Global Program contracts with anticipated multiple regional awards, positioning strategic vendors like AmerisourceBergen for continued federal pharmaceutical procurement support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 7/18/25 |